Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

K-RAS Protein (AA 2-185) (His tag)

KRAS Origin: Human Host: HEK-293 Cells Recombinant The purity of the protein is greater than 85 % as determined by SDS-PAGE and Coomassie blue staining.
Catalog No. ABIN7092804
  • Target See all K-RAS (KRAS) Proteins
    K-RAS (KRAS) (GTPase Kras (KRAS))
    Protein Type
    Recombinant
    Protein Characteristics
    AA 2-185
    Origin
    • 28
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Source
    • 22
    • 4
    • 3
    • 2
    • 2
    HEK-293 Cells
    Purification tag / Conjugate
    This K-RAS protein is labelled with His tag.
    Purpose
    Recombinant human KRAS protein with C-terminal 6xHis tag
    Specificity
    KRAS (Thr2-Cys185) 6xHis tag
    Characteristics
    Extracellular Domain Protein
    Purification
    Purified from cell culture supernatant by affinity chromatography
    Purity
    The purity of the protein is greater than 85 % as determined by SDS-PAGE and Coomassie blue staining.
    Top Product
    Discover our top product KRAS Protein
  • Restrictions
    For Research Use only
  • Format
    Lyophilized
    Buffer
    Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
    Storage
    -20 °C,-80 °C
    Storage Comment
    Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
    Expiry Date
    12 months
  • Target
    K-RAS (KRAS) (GTPase Kras (KRAS))
    Alternative Name
    KRAS (KRAS Products)
    Target Type
    Viral Protein
    Background
    This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. [provided by RefSeq, Jul 2008]
    Molecular Weight
    predicted molecular mass of 21.8 kDa after removal of the signal peptide. The apparent molecular mass of KRAS-His is 15-25 kDa due to glycosylation.
    UniProt
    P01116
You are here:
Support